antivir therapi human immunodefici viru infect children antiretrovir therapi children earli stage progress hour current standard therapi symptomat children low standard like clarifi optim dosag zdv differ popul children zdv need monthli hematolog side effect common ill children role newer antiretrovir ddi ddc like differ toxic profil zdv combin issu peripher neuropathi lack easi test ddc ddi young preverb children proposit zdv optimum dosag time ddc avail regimen combin therapi antiretrovir drug dideoxynucleosid high-tit antivir immunoglobulin technolog avail easi antisens oligom new technolog mani hurdl agent laboratori clinic goal agent site revers transcriptas reason work new categori drug difficult slow meantim children hiv effect antiretrovir regimen avail 